Skip to main content

Table 2 Characteristics of the institutions (N = 47)

From: Improving access to care in low and middle-income countries: institutional factors related to enrollment and patient outcome in a cancer drug access program

 

Institutions (N = 47)

%

Public

38

80.8

WHO regions

  
 

Africa

28

59.6

 

America

3

6.4

 

Eastern Europe

9

19.1

 

Pacifica

4

8.5

 

South East Asia

3

6.4

Specialized human resources*

  
 

Hematologist and oncologist

21

44.7

 

At least one hematologist or one oncologist

42

89.3

Research ability

12

25.5

Technical competency

  
 

Philadelphia or CD117

20

42.6

 

Bone marrow biopsy or aspiration

7

14.9

  1. *At time institutions were approved for participation in GIPAP.